Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Nanomaterials for Antiangiogenic Therapies for Cancer: A Promising Tool for Personalized Medicine.
Int J Mol Sci. 2021 Feb 5;22(4):1631. doi: 10.3390/ijms22041631.
Int J Mol Sci. 2021.
PMID: 33562829
Free PMC article.
Review.
Systematic Analysis of Spleen Tyrosine Kinase Expression and its Clinical Outcomes in Various Cancers.
Alwithenani AI, Althubiti MA.
Alwithenani AI, et al.
Saudi J Med Med Sci. 2020 May-Aug;8(2):95-104. doi: 10.4103/sjmms.sjmms_300_19. Epub 2020 Apr 17.
Saudi J Med Med Sci. 2020.
PMID: 32587490
Free PMC article.
Item in Clipboard
Molecular profiling of non-small cell lung cancer.
Forsythe ML, Alwithenani A, Bethune D, Castonguay M, Drucker A, Flowerdew G, French D, Fris J, Greer W, Henteleff H, MacNeil M, Marignani P, Morzycki W, Plourde M, Snow S, Xu Z.
Forsythe ML, et al. Among authors: alwithenani a.
PLoS One. 2020 Aug 5;15(8):e0236580. doi: 10.1371/journal.pone.0236580. eCollection 2020.
PLoS One. 2020.
PMID: 32756609
Free PMC article.
Item in Clipboard
Profiling non-small cell lung cancer reveals that PD-L1 is associated with wild type EGFR and vascular invasion, and immunohistochemistry quantification of PD-L1 correlates weakly with RT-qPCR.
Alwithenani A, Bethune D, Castonguay M, Drucker A, Flowerdew G, Forsythe M, French D, Fris J, Greer W, Henteleff H, MacNeil M, Marignani P, Morzycki W, Plourde M, Snow S, Marcato P, Xu Z.
Alwithenani A, et al.
PLoS One. 2021 May 6;16(5):e0251080. doi: 10.1371/journal.pone.0251080. eCollection 2021.
PLoS One. 2021.
PMID: 33956842
Free PMC article.
Item in Clipboard
Unlocking the potential of dimethyl fumarate: enhancing oncolytic HSV-1 efficacy for wider cancer applications.
Alwithenani A, Taha Z, Thomson M, Chen A, Wong B, Arulanandam R, Diallo JS.
Alwithenani A, et al.
Front Immunol. 2023 Dec 19;14:1332929. doi: 10.3389/fimmu.2023.1332929. eCollection 2023.
Front Immunol. 2023.
PMID: 38169670
Free PMC article.
Item in Clipboard
Pevonedistat, a first-in-class NEDD8-activating enzyme inhibitor, sensitizes cancer cells to VSVΔ51 oncolytic virotherapy.
Wong B, Bergeron A, Maznyi G, Ng K, Jirovec A, Birdi HK, Serrano D, Spinelli M, Thomson M, Taha Z, Alwithenani A, Chen A, Lorimer I, Vanderhyden B, Arulanandam R, Diallo JS.
Wong B, et al. Among authors: alwithenani a.
Mol Ther. 2023 Nov 1;31(11):3176-3192. doi: 10.1016/j.ymthe.2023.09.017. Epub 2023 Sep 27.
Mol Ther. 2023.
PMID: 37766429
Item in Clipboard
Cite
Cite